Online ISSN: 2515-8260

Author : Anitha, Dr. N.


MUCORMYCOSIS - A REVIEW

Dr. G. NISHANTH; Dr. N. Anitha; Dr. N.Aravindha Babu; Dr. L. Malathi

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 3, Pages 1786-1791

Mucormycosis is a rare angio invasive infection mainly recognized in immunocompromised patients which occurs due to the fungi mucorales. This rare fungal infection can be classified into rhino-orbitocerebral, cutaneous, disseminated, gastrointestinal, and pulmonary types. Inspiote of aggressive treatment once detected or diagnosed overall increased mortality rate is reported. This review aims in providing with brief details regarding the Etiopathogenesis of Mucormycosis, fatality of rhinocerebral Mucormycosis along with recent advances in diagnostic and treatment methods

SJOGREN’S SYNDROME-A REVIEW

Dr. S. Kowsalya; Dr. N.Aravindha Babu; Dr. K.M.K. Masthan; Dr. N. Anitha

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 3, Pages 1810-1820

Sjogren’s syndrome (SS) is a slowly progressive chronic autoimmune disease characterized bychronic inflammation of the exocrine glands. Xerostomia, Keratoconjuctivitis sicca and the B-lymphocytes hyperactivity are the characteristic features of the syndrome.Sjogren's syndrome (SS) also called as “Mikulicz disease” and “Sicca syndrome”. Lacrimal and salivary glands are most affected, which leading to mouth dryness and eye dryness.Sjogren syndrome can exist by itself known as primary Sjogren syndrome or associated with another disorders such as systemic sclerosis, rheumatoid arthritis, primary biliary cirrhosis or Hashimoto thyroiditis (associated secondary Sjogren syndrome).

Type of article: Review article Title of the article: SCHWANNOMA - A REVIEW

Dr. Malathi; Dr. G. Nishanth; Dr. N. Aravindha Babu; Dr. N. Anitha

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 4, Pages 1492-1494

Schwannomas are benign neoplasms with debatable etiology, which commonly arise from neural sheath Schwann cells. They are solitary, slow-growing lesions occurring at different ages especially in intraoral site. Lesions are normally asymptomatic and now and again, they are accompained by pain and paresthesia whenever seen in the intraosseous sites of the mandibles. Diagnosis of schwannoma is set up through histopathological assessment and immunohistochemical assessment, and the first line treatment includes the surgical removal of the tumor without affecting of neighboring structures. Anti-S100 protein is the most noteworthy antibody response used to recognize schwannomas. Schwannomas are known to have better prognosis, and if the lesion is totally excised, there is no chance of recurrence

Treatment options for Oral Potentially Malignant Disorder (OPMDs)

Dr B. Ishwariya; Dr. N.Aravindha Babu; Dr. K.M.K. Masthan; Dr. N. Anitha

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 3, Pages 1832-1843

Oral Cancer is a deadly infection, causing serious mortality and morbidity globally. Almost all oral cancerous lesions are derived from Oral potentially malignant disorder (OPMD). Among overall 60 to 70% of the Indian patients were introduced for therapy just in the advanced stage of oral malignant growth prompting a high death rate. The absence of public awareness about the screening and treatment during the premalignant stage along with the lack of knowledge for early detection by medical and health care providers are the main reason for this diagnostic delay and treatment initiation. This article aims to give different treatment options for Oral Potentially Malignant Disorder (OPMD) to prevent the progression of OPMD into malignancy.

Type of article: Review article Title of the article: MICROBIOME IN HEALTH AND DISEASED

Dr. N. Anitha; Dr. A.M. Sherene Christina Roshini; Dr.N.Aravindha Babu; Dr. E. Rajesh

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 4, Pages 1486-1491

Microbes continue to live on and within human beings. Intestinal microbial imbalance has a close relationship with human health and disease. This review article targets on the communication between human microbiome and host in order to provide an overview of the microbial role in biological processes and in major human diseases such as infectious diseases, liver diseases, gastrointestinal cancers, metabolic diseases, respiratory diseases, mental or psychological diseases, and autoimmune diseases. Hence research is necessary for understanding the role of microbiome in health and disease which pave the way for treatment approaches in clinical practice

Type of article: Review article Title of the article: SJOGREN’S SYNDROME IN DENTIST PERSPECTIVE- A REVIEW

Dr. G. Nishanth; Dr. N. Anitha; Dr. N. Aravindha Babu; Dr. K.M.K. Masthan

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 4, Pages 1495-1498

Sjogren’s syndrome (SS) is an autoimmune disorder which is responsible for glandular dysfunction most preferably salivary and lacrimal glands, caused mainly by the lymphocytic infiltration of exocrine glands. It can be classified into two, namely Primary Sjogren’s syndrome and Secondary Sjogren’s syndrome. Primary Sjogren’s syndrome (pSS) occurs in the absence of other autoimmune diseases and is characterised by keratoconjunctiva sicca (dry eyes) and xerostomia (dry mouth), collectively called the sicca syndrome. On the other hand, secondary Sjogren’s syndrome is associated with other autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The prevalence of SS is estimated to be approximately 3% in subjects 50 years or older, with a female to male ratio of 9:1. Conditions associated with SS include rheumatoid arthritis, lupus erythematosus and scleroderma. The clinical manifestations are often vague and mistakenly interpreted and attributed to other medical conditions or iatrogenic disorders. As such, incorrect diagnosis of SS is common and approximately half of all patients are thought to be undiagnosed